These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11435535)

  • 21. Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
    Hull JE; Hull MK; Urso JA
    J Vasc Interv Radiol; 2004 Jun; 15(6):557-64. PubMed ID: 15178715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefical effects of reteplase in combination with abciximab: platelet/leukocyte interactions and coagulation system.
    Szabo S; Walter T; Etzel D; Ehlers R; Kazmaier S; Beyer ME; Hoffmeister HM
    Int J Clin Pharmacol Res; 2003; 23(2-3):37-40. PubMed ID: 15018016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.
    Peter K; Kohler B; Straub A; Ruef J; Moser M; Nordt T; Olschewski M; Ohman ME; Kübler W; Bode C
    Circulation; 2000 Sep; 102(13):1490-6. PubMed ID: 11004138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction.
    Mak KH; Lee LH; Wong A; Chan C; Koh TH; Lau KW; Lim YL
    Am J Cardiol; 2002 Apr; 89(8):930-6. PubMed ID: 11950430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GUSTO V: should it affect clinical practice? Global Use of Strategies to Open Occluded Coronary Arteries.
    Orford JL; Berger PB
    Cleve Clin J Med; 2002 Jul; 69(7):520-2. PubMed ID: 12109634
    [No Abstract]   [Full Text] [Related]  

  • 26. Intra-arterial thrombolysis (reteplase) and ReoPro for subacute thrombosis of the distal aorta accomplished by radial arterial access: the radial-kissing-thrombolytic technique.
    de La Serna FA; Tolleson TR; Crowley JJ; Stack RS; Zidar JP
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):264-8. PubMed ID: 11387618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of abciximab after failed thrombolytic therapy.
    Cantor WJ; Kaplan AL; Velianou JL; Sketch MH; Barsness GW; Berger PB; Ohman EM
    Am J Cardiol; 2001 Feb; 87(4):439-42, A4. PubMed ID: 11179529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
    Antman EM; Gibson CM; de Lemos JA; Giugliano RP; McCabe CH; Coussement P; Menown I; Nienaber CA; Rehders TC; Frey MJ; Van der Wieken R; Andresen D; Scherer J; Anderson K; Van de Werf F; Braunwald E
    Eur Heart J; 2000 Dec; 21(23):1944-53. PubMed ID: 11071800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Too much, too little, or none at all: dealing with substandard and fake drugs.
    Wan Po AL
    Lancet; 2001 Jun; 357(9272):1904. PubMed ID: 11425409
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. A preliminary feasibility and safety study in a non-human primate model.
    Qureshi AI; Suri MF; Ali Z; Ringer AJ; Boulos AS; Nakada MT; Alberico RA; Martin LB; Guterman LR; Hopkins LN
    Neuroradiology; 2005 Nov; 47(11):845-54. PubMed ID: 16205896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination pharmacotherapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa inhibition.
    Bush HS
    J Emerg Med; 2003 Nov; 25(4):421-6. PubMed ID: 14654184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries.
    Askari AT; Lincoff AM
    Cleve Clin J Med; 2002 Jul; 69(7):554-60. PubMed ID: 12109639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries.
    Miller JM; Smalling R; Ohman EM; Bode C; Betriu A; Kleiman NS; Schildcrout JS; Bastos E; Topol EJ; Califf RM
    Am J Cardiol; 1999 Oct; 84(7):779-84. PubMed ID: 10513773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.
    Gibson CM; Anshelevich M; Murphy S; Luu L; Hynes C; Kliris J; Kermgard S; Otten MH; Antman EM; Cannon CP; Braunwald E;
    Am J Cardiol; 2000 Dec; 86(12):1378-9, A5. PubMed ID: 11113418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing regimen of reteplase and costeffectiveness.
    Hödl R; Kraxner W; Maier R; Klein W
    Lancet; 2001 Oct; 358(9291):1462. PubMed ID: 11705534
    [No Abstract]   [Full Text] [Related]  

  • 37. Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study.
    Heo JH; Lee KY; Kim SH; Kim DI
    Neurology; 2003 May; 60(10):1684-7. PubMed ID: 12771267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
    de Lemos JA; Gibson CM; Antman EM; Murphy SA; Morrow DA; Schuhwerk KC; Schweiger M; Coussement P; Van de Werf F; Braunwald E;
    Am Heart J; 2001 Apr; 141(4):592-8. PubMed ID: 11275925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
    Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
    Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.